Releases - DiaGenic ASA

View:

2010

 

Found press releases

 

Notification of trade among insiders

On 17 December 2010 mandatory notification of trade among insiders of DiaGenic ASA took place.

Henrik Lund, Chairman of the Board of DiaGenic ASA, has purchased 400,000 shares in DiaGenic ASA at a price of NOK 0.97 per share. After the transaction, Lund holds 400,000 shares in the Company.

Ingrid Wiik, Vice Chairman of the Board of DiaGenic ASA, has purchased 200,000 shares in DiaGenic ASA at an average price...

DiaGenic and Pfizer to collaborate on blood based biomarkers for early stages of...

Oslo – December 17, 2010: DiaGenic ASA  [OSL:DIAG] and Pfizer Inc [NYSE: PFE] today signed an agreement for explorative R&D collaboration to identify biomarkers in early stages of Alzheimer’s disease (AD) using DiaGenic’s patented gene expression technology and its blood samples from ongoing clinical studies.
The companies will perform a joint modular study where they will compare longitudinal changes in blood...

Financial calendar for 2011

-          4th quarter results 2010 and preliminary annual result for 2010: 18 February 2011

-          1st quarter results 2011: 12 May 2011

-          Annual General Meeting:  23 May2011

-          2nd quarter results 2011: 19 August 2011

-          3rd quarter results 2011: 28 October 2011

This information is subject to disclosure requirements according to §5-12 vphl (Norwegian Securities Trading...

Share capital increase

On 29 October 2010 the general assembly in DiaGenic ASA resolved a private placement of 140 million new shares and a subsequent offering of up to 60 million new shares, both at a subscription price of NOK 0.50 per share. The share capital increase from the subsequent offering of 60 million new shares has now been registered with the Norwegian Register of Business Enterprises. Following the registration, DiaGenic’s...

Mandatory notification of trades

DiaGenic today announce mandatory notification of trades among primary insiders of DiaGenic ASA which took place as part of the allotment of shares in the “Subsequent repair offering”. Reference is made to the notice to the stock exchange on 17 and 18 November 2010 regarding notification of trades among primary insiders which subscribed in the “Subsequent repair offering”, and the notice to the stock exchange on 23...

FINAL RESULT OF THE SUBSEQUENT OFFERING

Reference is made to the stock exchange notice dated 3 November 2010 and the prospectus dated 2 November 2010 regarding a subsequent offering of up to 60,000,000 offer shares in DiaGenic ASA (“DiaGenic” or the “Company”), each with a nominal value of NOK 0.05, at a subscription price of NOK 0.50 per share with subscription rights for shareholders of the Company as of 6 October 2010, except shareholders who were...

Preliminary result of the subsequent offering

Preliminary counts indicate that DiaGenic has received subscriptions for approximately 92,738,974 shares in the subsequent offering closed yesterday. This represents approximately 155 percent of the total number of offered shares in the subsequent offering. Allocation of offer shares to the subscribers is expected to be resolved by the board of directors of DiaGenic on or about 23 November 2010.

Notification of trade among primary insiders

Reference is made to the notice to the stock exchange on 3 November 2010 regarding commencement of subscription period for the “Subsequent repair offering”. On 17 November 2010 mandatory notification of trade among primary insiders of DiaGenic ASA took place. The transactions are described in detail below.

Maria Holmlund, board member in DiaGenic ASA, has received 11,756 subscription rights in the subsequent...

Notification of trade among primary insiders

Reference is made to the notice to the stock exchange on 3 November 2010 regarding commencement of subscription period for the “Subsequent repair offering”. On 16 November 2010 mandatory notification of trade among primary insiders of DiaGenic ASA took place. The transactions are described in detail below.

Atul Shah, board member in DiaGenic ASA, has through a related company received 2,006,377 subscription...

Notification of trade among primary insider

Reference is made to the notice to the stock exchange on 3 November 2010 regarding commencement of subscription period for the “Subsequent repair offering”. On 15 November 2010 mandatory notification of trade among primary insiders of DiaGenic ASA took place. The transaction is described in detail below.

Erik Anders Lönneborg, Director in DiaGenic ASA, received 3,107,397 subscription rights in the subsequent...

DiaGenic ASA

DiaGenic ASA is an innovative Norwegian life sciences company founded in 1998 and listed on the Oslo Stock Exchange.

DiaGenic develops patient-friendly tests for the early diagnosis of devastating diseases where early in...

View more


  CONTACT